More than 10 different drug types have been approved by the FDA for the treatment of melanoma, including dacarbazine chemotherapy, BRAF and MEK-targeted therapy, recombinant interferon alpha-2b and IL-2, immune checkpoint inhibitors (ICIs), and oncolytic viral therapy (T-VEC). Here, MAP2K7 is linked to melanoma.